Biomedtech Portfolio

Affluent Medical

Minimally invasive, biomimetic and adjustable solutions for mitral regurgitation and urinary incontinence

Affluent's Website

Affluent Medical, founded by Truffle Capital in 2011, is a clinical-stage MedTech company specialized in restorative minimally invasive implants for cardiac disease, vascular disease and urinary incontinence:

KALIOS: 1st mitral annuloplasty device that can be percutaneously adjusted to optimize valve repair at any time after implant
EPYGON: 1st physiological transcatheter mitral valve
ARTUS: 1st implantable artificial sphincter with pocket remote control suitable for both men and women

Kalios: Watch to Discover More

Epygon: Watch to Discover More

Artus: Watch to Discover More

LATEST NEWS

April 4, 2024

Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.

March 12, 2024

Interview of Philippe Pouletty regarding the firtst successful Artus in-human implantation

March 9, 2023

Affluent Medical announces initial success of first clinical implantation of its Epygon mitral heart valve via minimally invasive route

February 9, 2023

Affluent Medical announces the launch of a capital increase of around €13 million (with PSR maintained by shareholders)

Aix-en-Provence,, December 7, 2022

Affluent Medical announces the appointment of Michel Therin as Chairman of the Board of Directors

June 10, 2021

AFFLUENT MEDICAL announces the success of its initial public offering on the Euronext Paris regulated market

December 3, 2019

Affluent Medical announces first patient implanted in optimise II pivotal clinical study for Kalios, the minimally invasive mitral valve repair ring

OTHER COMPANIES

Abivax

Regulating the immune response through microRNA

Holistick Medical

Patent Foramen Ovale (PFO) treatment through next generation medical devices

Seacure

Seacure leverages natural processes to fight against coastal erosion and protect marine structures

Theraclion

Medical devices levaraging Focused Ultrasounds to treat varicose veins, Fibroadenoma and Thyroid...

Theradiag

In-vitro diagnostics for autoimmune diseases

Vexim

Minimally invasive spinal implant

Symetis

Minimaly invasive Aortic Valve

Carmat

First-of its kind implantable artificial heart

Evexta Bio

Developing Next Generation Precision Cancer Therapies

Spikimm

SpikImm develops long-acting mAbs to prevent viral infections in imunocompromized patients, in pa...